Home Financial Markets Key Secret behind DermTech, Inc. (DMTK) surge in the Afterhours

Key Secret behind DermTech, Inc. (DMTK) surge in the Afterhours

DermTech, Inc. (NASDAQ: DMTK) stock was rising 27.83% to reach $18.28 in the aftermarket following the published the topline results of the TRUST Study, a non-invasive melanoma rule-out test using the Pigmented Lesion Assay. The TRUST study was intended to assess the long-term outcomes of the PLA negative results of pigmented skin lesions. It also serves to support further the 99% negative predictive value of the PLA. To determine the proportion of true negative lesions among all those that tested negative, the study protocol called for retesting PLA-negative lesions 12 to 24 months before each subject’s enrollment in the TRUST Study.

It helps identify melanoma in the early stages by detecting atypical pigmented lesions to help rule out the melanoma and the need for surgical procedures. The PLA identifies the LINC 518 and PRAME genes in a two-panel gene expression assay.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Read More

The TRUST study was conducted at five clinical sites in the U.S. that use the PLA to help manage atypical pigmented lesions in their clinical practice.

An assessment of a long-term follow-up cohort of 1,781 lesions with PLA negative testing in a 12 to 24 month period preceding the study’s start resulted in 302 lesions undergoing PLA testing and meeting the study’s prespecified enrollment target.

NPV and patient outcome measures for the full cohort of eligible lesions were established by prospectively reviewing charts for any melanoma diagnoses on the PLA tested lesion, late-stage diagnoses of melanoma, and melanoma mortality. There were no deaths or diagnoses of late-stage melanoma in the full cohort of 1,781 lesions. In total, ten lesions from the full cohort were diagnosed with melanoma after initial testing, four of which were Stage 0 lesions (in situ) and six Stage 1a lesions.

A subset of the full cohort, representing 1,233 lesions, confirmed follow-up evaluations on the PLA-negative test, and we calculated an NPV of 99.2% (CI95%= 98.5 – 99.6) from these evaluations.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Inpixon (INPX) Building its Reputation in the market

INPX Getting Boost:  Inpixon recently got a huge amount of recognition from various firms. INPX company was commended by Gartner and by IoT Sensor company....

Top Recent Developments that lead to the ConforMIS Inc (CFMS) stock back on its track:

How CFMS performed: During a pandemic, different companies suffered from major losses. According to a study, there was a 53% reduction in adult heart surgeries....

The Reason Behind More Than 100% Pre-Market Rise Of NanoViricides, Inc. (NNVC) Stock

The stock of drug-maker NanoViricides, Inc. (NNVC) has been skyrocketing in the pre-market trades today. As of 08:24 a.m. EST, the stock was priced...

What Drove The STRATA Skin Sciences, Inc. (NASDAQ: SSKN) Stock In Extended Trading?

Shares of dermatology-focused company STRATA Skin Sciences, Inc. (NASDAQ: SSKN) leapt 15.03% to $1.99 in the trading after ring of the bell on Monday....

Why Sundial Growers (SNDL) shares have skyrocketed in intraday trading?

Shares of Sundial Growers (SNDL) have been on a skywalk. As of 10:47 AM EST, the seller, and producer of Cannabis products recorded $1.38...

Top Recent Developments that lead to the ConforMIS Inc (CFMS) stock back on its track:

How CFMS performed: During a pandemic, different companies suffered from major losses. According to a study, there was a 53% reduction in adult heart surgeries....

CHF Solutions, Inc. (CHFS): Why Is It Upticking Today?

The medical device company CHF Solutions, Inc. (Nasdaq: CHFS) started today’s trading on a positive note. As of 10:51 a.m. EST, the stock was...

Is It Because The Stock of Communications Systems, Inc. (JCS) Is Climbing 111% Pre-Market?

In pre-market session today, Communications Systems, Inc. (JCS) shares have been rising aggressively. As of 09:16 a.m. EST, the stock was at a rise...

Related News

Here’s What You Should Know About Just Energy Group Inc (JE) Stock

Just Energy Group Inc (JE)‎ stock has shown a rise in the last trading session. JE is a natural gas and electricity retailer based...

Castor Maritime (CTRM) Stock Sets Sails for A Strong Outlook in 2021

Castor Maritime (NASDAQ: CTRM) converged to a close at $1.00 which is a loss of 1.09%. This is a steep drop from the recent...

What Took Gabelli Healthcare (GRX) Stock Down 18% In Pre-Market?

The Gabelli Healthcare & Wellness Trust (GRX) is sinking -18.33% in pre-market trading today following the announcement of a cash distribution by the organization...

In Premarket, What Has Been Causing AmeriServ Financial (ASRV) Stock To Increase 100%?

AmeriServ Financial, Inc. (NASDAQ: ASRV) has been seeing price of its share rising more than 100% in pre-market session today. The holding firm of...

You Should Read THIS Before Investing In Hut 8 Mining Corp’s Ordinary Shares (OTC: HUTMF)

Hut 8 Mining Corp - Ordinary Shares (OTC-HUTMF) stock soared by 21.74% in the last trading session, reaching $10.390. Over the last month, the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.